Neogen Corporation Accounts Receivable, Allowance for Credit Loss, Recovery
Neogen Corporation (NEOG) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $46.00 thousand for the 12-month period ending 2023-05-31, per its 10-K filed 2023-08-15.
Discontinued › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2023-08-15
- Neogen Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2023 was $46.00K, a 53.06% decline from fiscal 2022.
- Neogen Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2022 was $98.00K, a 29.50% decline from fiscal 2021.
- Neogen Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2021 was $139.00K, a 183.67% increase from fiscal 2020.
- Neogen Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2020 was $49.00K, a 28.95% increase from fiscal 2019.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month as first filed |
|---|---|---|
| 2023-05-31 | $46.00K 10-K · filed 2023-08-15 | |
| 2022-05-31 | $98.00K 10-K · filed 2023-08-15 | |
| 2021-05-31 | $139.00K 10-K · filed 2023-08-15 | |
| 2020-05-31 | $49.00K 10-K · filed 2022-07-27 | |
| 2019-05-31 | $38.00K 10-K · filed 2021-07-30 | |
| 2018-05-31 | $40.00K 10-K · filed 2020-07-30 | |
| 2017-05-31 | $25.00K 10-K · filed 2019-07-30 | |
| 2016-05-31 | $90.00K 10-K · filed 2018-07-27 | |
| 2015-05-31 | $92.00K 10-K · filed 2017-07-28 | |
| 2014-05-31 | $8.00K 10-K · filed 2016-07-29 | |
| 2013-05-31 | $24.00K 10-K · filed 2015-07-30 | $24.03K 10-K · filed 2013-07-30 |
| 2012-05-31 | $12.00K 10-K · filed 2014-07-30 | $12.21K 10-K · filed 2013-07-30 |
| 2011-05-31 | $88.17K 10-K · filed 2013-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |